HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laura Balcer Selected Research

opicinumab

1/2019Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab.
10/2018Predictors of response to opicinumab in acute optic neuritis.
3/2017Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laura Balcer Research Topics

Disease

4COVID-19
01/2022 - 12/2020
4Optic Neuritis (Retrobulbar Neuritis)
01/2019 - 03/2017
4Multiple Sclerosis
11/2018 - 10/2006
3Relapsing-Remitting Multiple Sclerosis
07/2021 - 02/2013
2Dementia (Dementias)
01/2022 - 12/2021
2Cognitive Dysfunction
01/2022 - 01/2022
2Brain Diseases (Brain Disorder)
01/2022 - 12/2020
2Headache (Headaches)
01/2021 - 10/2015
2Migraine Disorders (Migraine)
01/2021 - 10/2015
2Ganglion Cysts (Ganglion)
11/2018 - 01/2018
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Fatigue
07/2021
1Spinal Cord Diseases
01/2021
1Meningitis
01/2021
1Myelitis
01/2021
1Tension-Type Headache (Tension Headache)
01/2021
1Headache Disorders (Headache Syndromes)
01/2021
1Post-Traumatic Headache
01/2021
1Encephalitis (Encephalitis, Rasmussen)
01/2021
1Acute Kidney Injury (Acute Renal Failure)
12/2020
1Hyponatremia
12/2020
1Renal Insufficiency (Renal Failure)
12/2020
1Atrophy
11/2018
1Weight Gain
10/2018
1Hypersensitivity (Allergy)
03/2017
1Neuromyelitis Optica (Devic's Disease)
04/2015
1Demyelinating Diseases (Demyelinating Disease)
10/2006

Drug/Important Bio-Agent (IBA)

4Retinaldehyde (Retinal)IBA
11/2018 - 01/2018
3opicinumabIBA
01/2019 - 03/2017
2Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2006
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2021 - 01/2021
2Natalizumab (Tysabri)FDA Link
07/2021 - 01/2021
1Biological ProductsIBA
01/2022
1Glial Fibrillary Acidic ProteinIBA
01/2022
1Amyloid beta-PeptidesIBA
01/2022
1Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA
01/2022
1SodiumIBA
12/2020
1Monoclonal AntibodiesIBA
01/2019
1Transaminases (Aminotransferases)IBA
03/2017
1Opioid Analgesics (Opioids)IBA
10/2015
1BarbituratesIBA
10/2015
1barbituric acid (barbiturate)IBA
10/2015
1Rituximab (Mabthera)FDA Link
04/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2015
1Azathioprine (Imuran)FDA LinkGeneric
04/2015
1Interferon-betaIBA
02/2013

Therapy/Procedure

2Therapeutics
01/2021 - 01/2008
1Length of Stay
12/2021
1Activities of Daily Living (ADL)
07/2021
1Autogenic Training
01/2021
1Artificial Respiration (Mechanical Ventilation)
12/2020